Golden Rice meets food safety standards of US food and drug agency
The United States Food and Drug Administration (US FDA) passed the food safety evaluation on GR2E Golden Rice, a provitamin-A biofortified rice variety.
In an official response received by the International Rice Research Institute (IRRI), the US FDA concurred with IRRI’s assessment regarding the safety and nutrition of Golden Rice.
The US FDA statement comes on the heels of the safety and nutrition approvals from Food Standards Australia New Zealand (FSANZ) and Health Canada received a few months ago.
These three national regulatory agencies carry out their assessments based on concepts and principles developed over more than two decades by international organizations such as the World Health Organization (WHO), the Food and Agriculture Organization (FAO) of the United Nations, the Organisation for Economic Co-operation and Development (OECD) and the Codex Alimentarius Commission.
“Each regulatory application that Golden Rice completes with national regulatory agencies takes us one step closer to bringing Golden Rice to the people who need it the most,” said IRRI Director General Matthew Morell.
“The rigorous safety standards observed by the US FDA and other agencies provide a model for decision-making in all countries wishing to reap the benefits of Golden Rice,” he added.
Once Golden Rice receives all necessary national approvals, a sustainable deployment program will ensure that Golden Rice is acceptable and accessible to its target communities.
Golden Rice is intended as a complementary, food-based solution to existing nutritional interventions, such as diet diversification and oral supplementation.
It achieves this by providing 30 percent to 50 percent of the estimated average requirement for Vitamin A of women and children.
GR2E Golden Rice is the first nutritionally enhanced genetically modified rice to receive regulatory approval for use in food.